Status:
UNKNOWN
Efficacy of Acupuncture Combined With Moving Cupping and Ear Point Tapping for Moderate and Severe Acne Vulgaris
Lead Sponsor:
Guang'anmen Hospital of China Academy of Chinese Medical Sciences
Conditions:
Acne Vulgaris
Eligibility:
All Genders
15-35 years
Phase:
NA
Brief Summary
This trial is designed to evaluate the efficacy of different frequencies in treating the moderate and severe acne vulgaris using acupuncture combined with moving cupping and ear point tapping.
Detailed Description
Background: Acne vulgaris is a common skin disease, especially in adolescents and young adults. Acne affects approximately 85% of teenagers, but can occur in most age groups and can persist into adult...
Eligibility Criteria
Inclusion
- Diagnosed as acne vulgaris.
- GAGS score between 19 and 38 points.
- Age of 15 to 35 years.
Exclusion
- Other types of acne: acne conglobate, acne fulminans，acne medicamentosa, premenstrual acne，cosmetic acne and trade acne.
- Presence of any other systemic disease that could affect the acne severity by its presence, such as polycystic ovarian syndrome, or thyroid diseases, or atypical congenital adrenal hyperplasia；or by any medication prescribed for the treatment of the systemic diseases.
- \-- Use of any topical acne treatment or systemic antibiotics or traditional Chinese medicine within 2 weeks before study initiation. Use of a systemic retinoid within 9 months before study initiation. Use of a systemic steroid within 9 months before study initiation. Presence of any change in the use of oral contraceptive pills or anti-inflammatory drugs within 3 months before study initiation.
- Presence of any other skin disease that could interfere with the assessment of the acne, such as folliculitis or rosacea.
- Presence of severe heart, liver, kidney or hematopoietic system diseases, as well as severe malnutrition.
- Pregnancy or lactation.
- Recent use of this research scheme within 4 weeks before study initiation.
Key Trial Info
Start Date :
September 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 30 2020
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT03264287
Start Date
September 1 2017
End Date
December 30 2020
Last Update
September 6 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Guang'anmen Hospital of China Academy of Chinese Medical Sciences
Beijing, Beijing Municipality, China, 100053